Stock Report: Omnicare Inc. (OCR) Report Updated: Jun 17, 2013 | Print This Page

Omnicare, Inc. operates as a healthcare services company that specializes in the management of pharmaceutical care in the United States and Canada. It provides pharmaceuticals, and related pharmacy and ancillary services to long-term care facilities, as well as chronic care facilities and other settings. The company operates institutional pharmacy business serving skilled nursing facilities, assisted living facilities, independent living communities, hospitals, correctional facilities, and other healthcare service providers; and offers pharmacy consulting services, including monthly patient drug therapy evaluations, assistance in compliance with state and federal regulations, and provision of proprietary clinical and health management programs. It also provides a suite of technology solutions based on its Omniview Web-based platform as the electronic ordering of prescription refills, proof-of-delivery tracking, and real-time validation of Medicare Part D coverage; intravenous medications and nutrition products, respiratory therapy services, medical supplies and equipment, and clinical care planning services; and pharmaceutical case management services for retirees, employees, and dependents. In addition, the company offers commercialization services for the biopharmaceutical industry; and end-of-life pharmaceutical care management for hospice care agencies. Its services include brand support services, third party logistics, patient assistance programs, specialty pharmacy, and disease management for end-of-life care. The company’s specialized drugs deal primarily with specific categories of drugs and disease states, such as rheumatoid arthritis, multiple sclerosis, oncology, and growth hormones. Omnicare, Inc. was founded in 1981 and is headquartered in Cincinnati, Ohio.